Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial
- Author
- MEHTA, Shamir R1 ; GRANGER, Christopher B2 ; FOX, Keith A. A8 ; YUSUF, Salim1 ; EIKELBOOM, John W1 ; BASSAND, Jean-Pierre3 ; WALLENTIN, Lars4 ; FAXON, David P5 ; PETERS, Ron J. G6 ; BUDAJ, Andrzej7 ; AFZAL, Rizwan1 ; CHROLAVICIUS, Susan1
[1] Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada
[2] Duke Clinical Research Institute, Duke University, Durham, North Carolina, United States
[3] centre Hospitalier Universitaire Jean Minjoz, Besançon, France
[4] Department of Medical Sciences and Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden
[5] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston , Massachusetts, United States
[6] Academic Medical Centre, Amsterdam, Netherlands
[7] Postgraduate Medical School, Department of Cardiology, Grochowski Hospital, Warsaw, Poland
[8] Royal Infirmary and University of Edinburgh, Edinburgh, Scotland, Canada - Source
Journal of the American College of Cardiology. 2007, Vol 50, Num 18, pp 1742-1751, 10 p ; ref : 20 ref
- CODEN
- JACCDI
- ISSN
- 0735-1097
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Elsevier Science, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Angioplastie Angor instable Appareil circulatoire Arthrose Artère coronaire Cardiologie Cardiopathie coronaire Complication Efficacité Enoxaparine sodique Essai clinique Etude comparative Fondaparinux sodique Homme Infarctus myocarde Inhibiteur enzyme Malade Oasis Phlébologie Résultat Stent Sécurité Toxicité Traitement instrumental Appareil circulatoire pathologie Arthropathie Maladie dégénérative Myocarde pathologie Système ostéoarticulaire pathologie
- Keyword (en)
- Angioplasty Variant angina Circulatory system Osteoarthritis Coronary artery Cardiology Coronary heart disease Complication Efficiency Enoxaparin sodium Clinical trial Comparative study Fondaparinux sodium Human Myocardial infarction Enzyme inhibitor Patient Oasis Phlebology Result Stent Safety Toxicity Instrumentation therapy Cardiovascular disease Arthropathy Degenerative disease Myocardial disease Diseases of the osteoarticular system
- Keyword (es)
- Angioplastia Angina inestable Aparato circulatorio Artrosis Arteria coronaria Cardiología Cardiopatía coronaria Complicación Eficacia Enoxaparina sódica Ensayo clínico Estudio comparativo Fondaparinux sódico Hombre Infarto miocardio Inhibidor enzima Enfermo Oasis Flebología Resultado Stent Seguridad Toxicidad Tratamiento instrumental Aparato circulatorio patología Artropatía Enfermedad degenerativa Miocardio patología Sistema osteoarticular patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A03 Coronary heart disease
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A05 Myocarditis. Cardiomyopathies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15E Osteoarthritis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B26 Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) / 002B26E Diseases of the cardiovascular system
- Discipline
- Cardiology. Circulatory system Osteoarticular pathology Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, speech therapy, crenotherapy. Dietary management and various treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19199134
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.jacc.2007.07.042 
https://dx.doi.org/10.1016/j.jacc.2007.07.042
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"50\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"1742\";s:8:\"\u0000*\u0000epage\";s:4:\"1751\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Shamir R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:22:\"GRANGER, Christopher B\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:12:\"YUSUF, Salim\";i:3;s:17:\"EIKELBOOM, John W\";i:4;s:20:\"BASSAND, Jean-Pierre\";i:5;s:15:\"WALLENTIN, Lars\";i:6;s:14:\"FAXON, David P\";i:7;s:16:\"PETERS, Ron J. G\";i:8;s:14:\"BUDAJ, Andrzej\";i:9;s:13:\"AFZAL, Rizwan\";i:10;s:19:\"CHROLAVICIUS, Susan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"50\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"1742\";s:8:\"\u0000*\u0000epage\";s:4:\"1751\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Shamir R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:22:\"GRANGER, Christopher B\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:12:\"YUSUF, Salim\";i:3;s:17:\"EIKELBOOM, John W\";i:4;s:20:\"BASSAND, Jean-Pierre\";i:5;s:15:\"WALLENTIN, Lars\";i:6;s:14:\"FAXON, David P\";i:7;s:16:\"PETERS, Ron J. G\";i:8;s:14:\"BUDAJ, Andrzej\";i:9;s:13:\"AFZAL, Rizwan\";i:10;s:19:\"CHROLAVICIUS, Susan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"50\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"1742\";s:8:\"\u0000*\u0000epage\";s:4:\"1751\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Shamir R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:22:\"GRANGER, Christopher B\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:12:\"YUSUF, Salim\";i:3;s:17:\"EIKELBOOM, John W\";i:4;s:20:\"BASSAND, Jean-Pierre\";i:5;s:15:\"WALLENTIN, Lars\";i:6;s:14:\"FAXON, David P\";i:7;s:16:\"PETERS, Ron J. G\";i:8;s:14:\"BUDAJ, Andrzej\";i:9;s:13:\"AFZAL, Rizwan\";i:10;s:19:\"CHROLAVICIUS, Susan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"50\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"1742\";s:8:\"\u0000*\u0000epage\";s:4:\"1751\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Shamir R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:22:\"GRANGER, Christopher B\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:12:\"YUSUF, Salim\";i:3;s:17:\"EIKELBOOM, John W\";i:4;s:20:\"BASSAND, Jean-Pierre\";i:5;s:15:\"WALLENTIN, Lars\";i:6;s:14:\"FAXON, David P\";i:7;s:16:\"PETERS, Ron J. G\";i:8;s:14:\"BUDAJ, Andrzej\";i:9;s:13:\"AFZAL, Rizwan\";i:10;s:19:\"CHROLAVICIUS, Susan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jacc.2007.07.042\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:9:\"\u0000*\u0000jtitle\";s:45:\"Journal of the American College of Cardiology\";s:9:\"\u0000*\u0000stitle\";s:20:\"J. Am. Coll. Cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"50\";s:8:\"\u0000*\u0000issue\";s:2:\"18\";s:8:\"\u0000*\u0000spage\";s:4:\"1742\";s:8:\"\u0000*\u0000epage\";s:4:\"1751\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0735-1097\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Shamir R\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:22:\"GRANGER, Christopher B\";i:1;s:15:\"FOX, Keith A. A\";i:2;s:12:\"YUSUF, Salim\";i:3;s:17:\"EIKELBOOM, John W\";i:4;s:20:\"BASSAND, Jean-Pierre\";i:5;s:15:\"WALLENTIN, Lars\";i:6;s:14:\"FAXON, David P\";i:7;s:16:\"PETERS, Ron J. G\";i:8;s:14:\"BUDAJ, Andrzej\";i:9;s:13:\"AFZAL, Rizwan\";i:10;s:19:\"CHROLAVICIUS, Susan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACCDI\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:174:\"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention : Results from the OASIS-5 trial\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
